ElevateBio Information
Contact top employees from
ElevateBio
Summary
ElevateBio is a private company that has been in the industry for 8 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the Chairman & CEO is occupied by David Hallal. Its headquarters is located at Waltham, Massachusetts, USA. The number of employees ranges from 25 to 100. The annual revenue of ElevateBio varies between 100K and 5.0M. Total funding of the company - $845M. To connect with ElevateBio employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
200-500 employees
Specialties
cell therapy, gene therapy, cell and gene therapy
SIC Code
2836, 8731
DMA Code
Greater Boston
Founded
2017
Estimated Annual Revenue
$100K - 5.0M
Operating Status
Independent Company
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2018 | Privately Held | 25 - 100 | 2M | $109M | |
| 2011 | Privately Held | 100 - 250 | 225.1M | $220.1M | |
| 2017 | Privately Held | 25 - 100 | < 1M | $165M | |
| 2015 | Privately Held | 25 - 100 | 6M | $36M | |
| 2000 | Privately Held | 100 - 250 | 20M | $2M | |
| 2014 | Public Company | 100 - 250 | 132.2M | $267.1M | |
| 2013 | Public Company | 100 - 250 | 24.6M | $407.5M | |
| 2020 | - | 1 - 25 | < 1M | $50M | |
| 2019 | - | 10-50 | < 1M | $0 | |
| 2015 | - | 200-500 | - | $- | |
| 2020 | - | 10-50 | - | $- | |
| 2016 | - | 100-200 | - | $- | |
| 2011 | - | 100-200 | - | $- | |
| 2008 | - | 200-500 | - | $- |
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Current employees switched from
Length of Employment
Employee tenure at ElevateBio shows a diverse range of experience levels:
8% have been with the company for less than 1 year34% for 1–2 years37% for 3–4 years13% for 5–7 years3% for 8–10 years5% have over 11 years of service at ElevateBioEx-employees positions
In Company
In New Company
Contact top employees from
ElevateBio
Becky Zoccola
Executive Director, Talent Acquisition & People Experience
June Jennings
Associate Director, Contracts Administration
Christine Leu
Senior Manager in Financial Planning & Analysis
Brigid Hayes
Associate Director - Digital Technology
Arielle Lodish
Senior Manager, BaseCamp Business Development
Brian Majors
VP, Head of Program Management
Sophia Kotsalidis
Director Engineering - Process and Validation
Victoria West
Associate Director, People Optimization and Analytics
Shona Robinson
Senior Associate Scientist Molecular/ Viral Vector Biology
Kate Lucich
Senior Associate Scientist, Pluripotent Stem Cell Process Development - Regenerative Medicine Group
Anand Ganesh
Director, Supply Chain Systems and Analytics
Ghulam Memon
Principal Cloud Architect
Lisa Gilliatt
Senior Manager, Supply Chain Systems, IT
Adam Hallet
Senior Manager, Manufacturing Science and Technology
Michael Giffin
Director, Analytical Development
shivangi shah
Principle Research Associate Scientist at ElevateBio
Jennifer Rivard
Senior Quality Assurance Specialist
Christine Corl
Director, Quality Control
Riza Salazar
Senior Manager, Validation Engineering
Jim Mullin
Associate Director, Warehousing and Material Management
Mario Miele
Senior Vice President, Facilities & Engineering
Ger Brophy
Chief Executive Officer
Adriana Geldart
Senior Director, Next-Generation Sequencing
James Timmins
Analyst II, Supply Chain Planning
Charles Muller
Senior Manager Microbiology
Anthony Venezia
Manager F&E Planning and Scheduling
Jennifer Tam
Associate Director, Financial Planning & Analysis
Similar Companies
FAQ
ElevateBio operates in the Biotechnology industries. More details can be found on the official website: elevate.bio.
The headquarters of ElevateBio are located in Waltham, United States.
The current CEO of ElevateBio is David Hallal
You can contact ElevateBio by phone at 617-433-2600.
ElevateBio currently employs 200-500 people.
ElevateBio's revenue is approximately 2.5M.
Well-known competitors of ElevateBio include Dyno Therapeutics, Translate Bio, A Sanofi Company, Tango Therapeutics and Verge Genomics.
